5 things to know about Taiwan’s healthcare landscape: Regulations & reimbursement

A new report from Research and Markets examines the healthcare regulatory and reimbursement landscape in Taiwan.

Advertisement

Here are five things to know:

 

1. Taiwan’s population increased from 2008 to 2013 from 23 million to 23.4 million due to rising life expectancy, but birth rate decreased at a negative compound annual growth rate of 0.2 percent.

 

2. The pharmaceutical market was estimated at $5.4 billion in 2013 and is projected to jump to $8.4 billion by 2020; that’s a compound annual growth rate of 6.4 percent.

 

3. The medical device market was worth $2.2 billion in 2013 and is expected to reach $3.1 billion by 2020.

 

4. The medical device market is expected to grow at a compound annual growth rate of 5.3 percent primarily due to increasing elderly populations and universal healthcare coverage.

 

5. The government initiatives, including reduced income tax for new pharmaceutical companies establishing themselves in Taiwan, are expected to encourage foreign companies to invest there, further boosting the market.

 

More articles on healthcare:
11 tips for keeping HIPAA compliance in the digital age
10 key apps for nurses
7 things to know about endoscopy competency training

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.